Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ MRPL54 Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA559875
Description
Immunogen sequence: ATKRLFGATR TWAGWGAWEL LNPATSGRLL ARDYAKKPVM KGAKSGKGAV TSEALKDPDV C Highest antigen sequence identity to the following orthologs: Mouse - 49%, Rat - 54%.
Mammalian mitochondrial ribosomal proteins are encoded by nuclear genes and help in protein synthesis within the mitochondrion. Mitochondrial ribosomes (mitoribosomes) consist of a small 28S subunit and a large 39S subunit. They have an estimated 75% protein to rRNA composition compared to prokaryotic ribosomes, where this ratio is reversed. Another difference between mammalian mitoribosomes and prokaryotic ribosomes is that the latter contain a 5S rRNA. Among different species, the proteins comprising the mitoribosome differ greatly in sequence, and sometimes in biochemical properties, which prevents easy recognition by sequence homology. This gene encodes a 39S subunit protein. [provided by RefSeq, Jul 2008].
Specifications
MRPL54 | |
Polyclonal | |
Unconjugated | |
Mrpl54 | |
0610008M19Rik; 39S ribosomal protein L54, mitochondrial; D10Sut1e; L54mt; Mitochondrial large ribosomal subunit protein mL54; mitochondrial ribosomal protein L54; Mrpl54; MRP-L54 | |
Rabbit | |
Antigen affinity chromatography | |
RUO | |
116541 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Immunohistochemistry (Paraffin) | |
0.2 mg/mL | |
PBS with 40% glycerol and 0.02% sodium azide; pH 7.2 | |
Q6P161 | |
Mrpl54 | |
Recombinant protein corresponding to Human MRPL54. Recombinant protein control fragment (Product #RP-99194). | |
100 μL | |
Primary | |
Human | |
Antibody | |
IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction